# Thyme Care Raises $125M+ Series E at $2B+ Valuation

On September 2, 2026, per PR Newswire, oncology patient navigation and value-based care company Thyme Care closed over $125M in a Series E led by Morgan Health with Humana, CVS Health Ventures and a16z Bio + Health at a valuation above $2B. The company was co-founded by Robin Shah and oncologist Bobby Green.



Canonical: https://uniquebase.ai/news/9406a621-60e9-4c32-8bec-f294a03d8ce7
Stable identifier: 9406a621-60e9-4c32-8bec-f294a03d8ce7
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:21:32.462Z

## Connected profiles

- [CVS Health Ventures](/institutions/cvs-health-ventures)
- [Humana](/institutions/humana)
- [Morgan Health](/institutions/morgan-health)
- [Thyme Care](/companies/thyme-care)
- [a16z Bio + Health](/institutions/a16z-bio-health)

## Sources

- https://www.prnewswire.com/news-releases/thyme-care-closes-125-million-series-e-establishes-thyme-co